Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved gene expression pattern using Epstein-Barr virus (EBV)-based plasmid and cationic emulsion.

Kyoung Ah Min1, Suk Kyeong Lee, Chong-Kook Kim

  • 1Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, San 56-1, Shillim-dong, Kwanak-gu, Seoul 151-742, Republic of Korea.

Biomaterials
|September 17, 2004
PubMed
Summary

This study developed a novel non-viral gene delivery system using an Epstein-Barr virus (EBV)-based plasmid and cationic emulsion. This complex enhances transgene expression, offering a promising tool for gene therapy applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amphibian Skin-Derived Peptides as Emerging Therapeutic Scaffolds for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Identification of Bioactive Medium Chain Fatty Acids (C<sub>10</sub>, C<sub>8</sub>, and C<sub>6</sub>) in Ozonated Sunflower Oil: Comparative Evaluation of Their Potent Antioxidant Activities and Anti-Inflammatory Effects in the Hyperinflammatory Zebrafish Model.

Antioxidants (Basel, Switzerland)·2026
Same author

Epstein-Barr Virus Silences GSDME and Pyroptosis in Gastric Cancer.

Microorganisms·2025
Same author

Epstein-Barr Virus Promotes Gastric Cancer Progression by Modulating m6A-Dependent YTHDF1-TSC22D1 Axis.

Microorganisms·2025
Same author

Combined Esculentin-2CHa Fusion Protein-Coated Au Nanoparticles for Effective Against Non-Alcoholic Fatty Liver Disease in Mice Model.

International journal of nanomedicine·2025
Same author

Long-Lasting Exendin-4-Coated Gold Nanoparticles: Synthesis and In Vivo Evaluation of Hypoglycemic Activity.

Pharmaceuticals (Basel, Switzerland)·2024

Area of Science:

  • Biotechnology
  • Gene Delivery Systems
  • Nanotechnology

Background:

  • Non-viral gene delivery systems are crucial for therapeutic applications but often face challenges with efficiency and transgene expression.
  • Epstein-Barr virus (EBV)-based plasmids offer unique advantages for gene expression due to their replication machinery.

Purpose of the Study:

  • To develop and evaluate a novel non-viral gene delivery complex combining an EBV-based plasmid with a cationic emulsion.
  • To assess the physical characteristics, stability, and transfection efficiency of the developed complex.

Main Methods:

  • Formulation of a cationic emulsion using castor oil and DC-Chol.
  • Construction of an EBV-based plasmid containing oriP and EBNA-1.
  • Characterization of emulsion and complex physical properties (particle size, zeta potential).

Related Experiment Videos

  • Transfection of cell lines with the complex and evaluation of green fluorescent protein (GFP) expression.

    • Main Results:

    • The cationic emulsion exhibited stable particle size (96 nm) and positive zeta potential (+17 mV).
    • The emulsion/DNA complex showed increased zeta potential and decreased particle size (200-300 nm) with higher emulsion ratios.
    • The complex demonstrated stability against DNase I and comparable transfection efficiency to Lipofectin across tested cell lines.
    • Enhanced and prolonged gene expression was observed using the EBV-based plasmid and cationic emulsion complex.

    Conclusions:

    • The combination of a physically stable cationic emulsion with a self-replicating EBV-based plasmid significantly enhances transgene expression.
    • This novel gene delivery complex presents a potent strategy for improving the efficacy of gene therapy.
    • The developed system shows promise for advanced gene delivery applications.